Analyst Stays Positive in DSW, With More Conservative Targets
DSW Inc. (NYSE: DSW) may still have a positive analyst view, but one of the targets just was brought down to a much more conservative level.
DSW Inc. (NYSE: DSW) may still have a positive analyst view, but one of the targets just was brought down to a much more conservative level.
Market skeptics are likely to keep maintaining that the annualized GDP recovery from the recession has been the weakest post-recession recovery since before World War II.
William C. Dudley, president and chief executive officer of the Federal Reserve Bank of New York, spoke at an Economic Press Briefing on Wednesday.
Fitch Ratings has issued one of those reports that may actually move some of the most negative views from investors either more positive or at least toward being less negative.
In its recent forecast of farm sector income and finances, the USDA’s Economic Research Services projects farm sector profitability will decline for the second straight year in 2015.
3M announced on Wednesday that it has completed its acquisition of Polypore International’s Separations Media business for the agreed-to price of $1 billion.
In a new report, Jefferies is out with its top value calls for this week, and we found four that make good sense now.
Acelity Holdings has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
The U.S. Department of Commerce has reported that durable goods orders were rather durable in July.
Independent research firm Argus has decided that the time to upgrade IBM is now.
Credit Suisse continues to see compelling value in Exelon shares even after the sell-off and the setback in its effort to buy Pepco.
Short interest during the two-week period ending August 14 rose on all four 3D printing stocks we follow.
The Merrill Lynch team suggest rotating out of momentum and looking at half yield and half growth stocks, or what they call Quintile 2 stocks.
Short interest moves among solar and alternative energy stocks were mixed during the two-week reporting period that ended on August 14.
The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of stocks.